De Luca R - Search Results

1

Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an Italian clinical experience.

Cicero G, De Luca R. Cicero G, et al. Among authors: de luca r. Eur Rev Med Pharmacol Sci. 2011 Mar;15(3):325-31. Eur Rev Med Pharmacol Sci. 2011. PMID: 21528780

2

Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study.

Cicero G, De Luca R, Dorangricchia P, Galvano A, Lo Re G, Serretta V, Dispensa N, Dieli F. Cicero G, et al. Among authors: de luca r. Oncology. 2017;92(2):94-100. doi: 10.1159/000452491. Epub 2016 Dec 14. Oncology. 2017. PMID: 27960186

3

The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study.

Cicero G, DE Luca R, Dorangricchia P, Dieli F. Cicero G, et al. Among authors: de luca r. Anticancer Res. 2017 Mar;37(3):1475-1480. doi: 10.21873/anticanres.11472. Anticancer Res. 2017. PMID: 28314320 Clinical Trial.

4

Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: a retrospective study.

Cicero G, De Luca R, Blasi L, Pepe A, Pavone C, Simonato A, Dieli F. Cicero G, et al. Among authors: de luca r. Anticancer Drugs. 2017 Oct;28(9):1047-1052. doi: 10.1097/CAD.0000000000000549. Anticancer Drugs. 2017. PMID: 28857768

5

Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experience.

Cicero G, Lo Re G, DE Luca R, Vernuccio F, Picone D, Midiri M, Lagalla R. Cicero G, et al. Among authors: de luca r. Anticancer Res. 2017 Sep;37(9):5187-5192. doi: 10.21873/anticanres.11941. Anticancer Res. 2017. PMID: 28870953

6

Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.

Cicero G, De Luca R, Dieli F. Cicero G, et al. Among authors: de luca r. Oncology. 2017;93(6):354-358. doi: 10.1159/000479112. Epub 2017 Sep 6. Oncology. 2017. PMID: 28873372

7

The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.

De Luca R, Costa RP, Tripoli V, Murabito A, Cicero G. De Luca R, et al. Oncology. 2018;94(3):161-166. doi: 10.1159/000485102. Epub 2017 Dec 15. Oncology. 2018. PMID: 29241166

8

Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer.

De Luca R, Blasi L, Alù M, Gristina V, Cicero G. De Luca R, et al. Drug Des Devel Ther. 2018 Jun 19;12:1769-1775. doi: 10.2147/DDDT.S165851. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29950811 Free PMC article.

9

Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.

De Luca R, Profita G, Vella M, Cicero G. De Luca R, et al. Oncology. 2019;97(6):341-347. doi: 10.1159/000502116. Epub 2019 Aug 28. Oncology. 2019. PMID: 31461721

10

Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): efficacy, tolerability and Quality of Life.

De Luca R, Alù M, Genova G, Grassadonia A, Cicero G. De Luca R, et al. Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12727-12734. doi: 10.26355/eurrev_202012_24171. Eur Rev Med Pharmacol Sci. 2020. PMID: 33378020 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters